These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38632600)

  • 1. Lipid metabolic reprogramming mediated by circulating Nrg4 alleviates metabolic dysfunction-associated steatotic liver disease during the early recovery phase after sleeve gastrectomy.
    Yang C; Zhu D; Liu C; Wang W; He Y; Wang B; Li M
    BMC Med; 2024 Apr; 22(1):164. PubMed ID: 38632600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics analyses decipher intricate changes in the cellular and metabolic landscape of steatotic livers upon dietary restriction and sleeve gastrectomy.
    Chen S; Zeng Q; Cai X; Xue J; Yin G; Song P; Tang L; Klein C; Tacke F; Guillot A; Liu H
    Int J Biol Sci; 2024; 20(11):4438-4457. PubMed ID: 39247824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrg4 promotes fuel oxidation and a healthy adipokine profile to ameliorate diet-induced metabolic disorders.
    Chen Z; Wang GX; Ma SL; Jung DY; Ha H; Altamimi T; Zhao XY; Guo L; Zhang P; Hu CR; Cheng JX; Lopaschuk GD; Kim JK; Lin JD
    Mol Metab; 2017 Aug; 6(8):863-872. PubMed ID: 28752050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis.
    Wang GX; Zhao XY; Meng ZX; Kern M; Dietrich A; Chen Z; Cozacov Z; Zhou D; Okunade AL; Su X; Li S; Blüher M; Lin JD
    Nat Med; 2014 Dec; 20(12):1436-1443. PubMed ID: 25401691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress inhibitor may substitute for sleeve gastrectomy to alleviate metabolic dysfunction-associated steatotic liver disease.
    Pei E; Wang H; Li Z; Xie X; Cai L; Lin M
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102229. PubMed ID: 37865225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
    Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N
    Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities.
    De Vuono S; Ricci MA; Nulli Migliola E; Monti MC; Morretta E; Boni M; Ministrini S; Carino A; Fiorucci S; Distrutti E; Lupattelli G
    Obes Surg; 2019 Aug; 29(8):2517-2526. PubMed ID: 31069691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study.
    Chen X; Peng R; Peng D; Liu D; Li R
    J Transl Med; 2024 Jul; 22(1):701. PubMed ID: 39075482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleeve-gastrectomy results in improved metabolism and a massive stress response of the liver proteome in a mouse model of metabolic dysfunction-associated steatohepatitis.
    Kroh A; Schmitz S; Köhne S; Andruszkow J; Nolting J; Preisinger C; Große K; Eickhoff RM; Heise D; Cramer T; Rheinwalt KP; Alizai PH; Neumann UP; Ulmer TF
    Heliyon; 2024 Nov; 10(21):e38678. PubMed ID: 39524892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sleeve gastrectomy and dietary change on metabolic and hepatic function in an obesity rat model - Experimental research.
    Dohmen J; Praktiknjo M; Rudeloff A; Uschner FE; Klein S; Plamper A; Matthaei H; Rheinwalt KP; Wehner S; Kalff JC; Trebicka J; Lingohr P
    Int J Surg; 2020 Mar; 75():139-147. PubMed ID: 32014594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy.
    Chow MD; Otersen K; Wassef A; Kong B; Yamarthy S; Rizzolo D; Yang I; Buckley B; Lu A; Crook N; Lee M; Gao J; Naganand S; Stofan MF; Armstrong L; Schumacher J; Taylor R; Henry Z; Basaly V; Yang Z; Zhang M; Huang M; Kagan L; Brunetti L; Sadek R; Lee YH; Guo GL
    Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38780301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    Zou Z; Liu X; Yu J; Ban T; Zhang Z; Wang P; Huang R; Zheng F; Chang Y; Peng W; Tang Y; Feng X; Zhao Z; Lv X; Huang S; Guo J; Tuo Y; Zhou Z; Liang S
    J Hepatol; 2024 Jun; 80(6):834-845. PubMed ID: 38331323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of
    Li Y; Jin L; Jiang F; Yan J; Lu Y; Yang Q; Zhang Y; Zhang H; Yu H; Zhang Y; He Z; Zhang R; Yang J; Hu C
    Diabetes; 2021 Oct; 70(10):2213-2224. PubMed ID: 34261740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric bypass specifically impairs liver parameters as compared with sleeve gastrectomy, independently of evolution of metabolic disorders.
    Ledoux S; Sami O; Calabrese D; Le Gall M; Flamant M; Coupaye M
    Surg Obes Relat Dis; 2019 Feb; 15(2):220-226. PubMed ID: 30598254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of PCSK9 in metabolic dysfunction-associated steatotic liver disease and its impact on bariatric surgery outcomes.
    Castellano-Castillo D; Núñez-Sánchez MÁ; Balaguer-Román A; Martínez-Sánchez MA; Fernández-Ruiz VE; Ferrer-Gómez M; Martínez CM; Frutos MD; Queipo-Ortuño MI; Cardona F; Ramos-Molina B
    Surg Obes Relat Dis; 2024 Jul; 20(7):652-659. PubMed ID: 38490825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of transient elastography in diagnosing MAFLD and the early effects of sleeve gastrectomy on MAFLD among the Chinese population.
    Hu R; Wu B; Wang C; Wu Z; Zhang X; Chen X; Lu G; Yuan K
    Int J Surg; 2024 Apr; 110(4):2044-2054. PubMed ID: 38215263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleeve Gastrectomy Improves Glycemia Independent of Weight Loss by Restoring Hepatic Insulin Sensitivity.
    Abu-Gazala S; Horwitz E; Ben-Haroush Schyr R; Bardugo A; Israeli H; Hija A; Schug J; Shin S; Dor Y; Kaestner KH; Ben-Zvi D
    Diabetes; 2018 Jun; 67(6):1079-1085. PubMed ID: 29475831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. n-3 PUFAs protect against adiposity and fatty liver by promoting browning in postnatally overfed male rats: a role for NRG4.
    Yang F; Zhou N; Zhu X; Min C; Zhou W; Li X
    J Nutr Biochem; 2021 Jul; 93():108628. PubMed ID: 33705952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity.
    Núñez-Sánchez MÁ; Martínez-Sánchez MA; Martínez-Montoro JI; Balaguer-Román A; Murcia-García E; Fernández-Ruiz VE; Ferrer-Gómez M; Martínez-Cáceres CM; Sledzinski T; Frutos MD; Hernández-Morante JJ; Fernández-García JC; Queipo-Ortuño MI; Ruiz-Alcaraz AJ; Mika A; Ramos-Molina B
    J Clin Endocrinol Metab; 2024 Jun; 109(7):1781-1792. PubMed ID: 38217869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the association of neuregulin 4, a brown fat-enriched secreted factor, with obesity and related metabolic disturbances.
    Tutunchi H; Ostadrahimi A; Hosseinzadeh-Attar MJ; Miryan M; Mobasseri M; Ebrahimi-Mameghani M
    Obes Rev; 2020 Feb; 21(2):e12952. PubMed ID: 31782243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.